期刊文献+

慢性疼痛基因治疗相关研究的进展 被引量:2

Advances in the study on gene therapy for chronic pain
原文传递
导出
摘要 Chronic pain is associated with alterations of neuronal systems involved in pain processing.Some suffering patients are not satisfactorily managed with currently available treatments.However,advances in the field of vector systems which have lower levels of inflammatory and immune responses,along with significant increases in our understanding of pain generating mechanisms and knowledge of tight control of transgene expression,will make gene-based approaches for the future management of pain a conceivable reality. Chronic pain is associated with alterations of neuronal systems involved in pain processing. Some suffering patients are not satisfactorily managed with currently available treatments. However, advances in the field of vector systems which have lower levels of inflammatory and immune responses, along with significant increases in our understanding of pain generating mechanisms and knowledge of tight control of transgene expression, will make gene - based approaches for the future management of pain a conceivable reality.
作者 董刚 俞卫锋
出处 《国际麻醉学与复苏杂志》 CAS 2006年第5期316-319,共4页 International Journal of Anesthesiology and Resuscitation
  • 相关文献

参考文献20

  • 1Pohl M, Meunier A, Hamon M, et al. Gene therapy of chronic pain. Current Gene Therapy, 2003, 3:223-238.
  • 2Julius D, Basbaum AI. Molecular mechanisms of nociception. Nature,2001,413 (6852) :203-210.
  • 3阎雪彬,王明安.慢性疼痛基因治疗的研究现状与展望[J].中国疼痛医学杂志,2003,9(2):111-114. 被引量:10
  • 4Castro M, Goverdhana S, Hu J, et al. Gene therapy for pituitary tumors: from preclinical models to clinical implementation. Front Neuroendocrinol, 2003, 24( 1 ) :62-77.
  • 5Cao H, Koehler DR, Hu J.Adenoviral vectors for gene replacement therapy. Viral Immunol, 2004,17 ( 3 ) :327-333.
  • 6Croyle MA, Le HT, Linse KD, et al. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile.Gene Ther, 2005, 12(7) :579-587.
  • 7Mok H, Palmer DJ, Ng P, et al. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther, 2005,11 ( 1 ) :66-79.
  • 8Mata M, Glorioso JC, Fink DJ. Targeted gene delivery to the nervous system using herpes simplex virus vectors. Physiol Behav, 2002,77 (4-5 ) :483-488.
  • 9Zaupa C, Revol-Guyot V, Epstein AL. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using CreloxP site-specific recombination to delete the packaging signals of defective helper genomes. Hum Gene Ther, 2003,14 ( 11 ) : 1049-1063.
  • 10Ralph GS, Bienemann A, Harding TC, et al. Targeting of tetracycline-regulatable transgene expression specifically to neuronal and glial cell populations using adenoviral vectors. Neuroreport, 2000, 11(9) :2051-2055.

二级参考文献25

  • 1[1]Wu HH,Wilcox GL,Mcloon SC.Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance.J Neurosci,1994,14:4806~4814.
  • 2[2]Sagen J. Cellular transplantation for intractable pain. Adv Pharmacol, 1998, 42:579~582.
  • 3[3]Iadarola MJ, Lee S, Mannes AJ. Gene transfer approaches to pain control. Molecular Neurobiology of Pain ,1997; (IASP Press, Seattle W.A.).
  • 4[4]Anderson WF. Human gene therapy. Nature (London), 1998, 392: 25~30.
  • 5[5]Dai Y, Roman M, Naviaux RK, et al. Gene therapy via primary myoblasts: long term expression of factor IX protein following transplantation in vivo. Proc Natl Acad Sci USA, 1992, 89:10892~10895.
  • 6[6]Yu XM, Salter MW. Src, a molecular switch governing gain control of synaptic transmission mediated by N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA, 1999, 96:7697~704.
  • 7[7]Garry MG, Malik S, Yu J, et al. Knock down of spinal NMDA receptors reduces NMDA and formalin evoked behaviors in rat. Neuroreport, 2000, 11:49~55.
  • 8[8]Finegold AA, Perez FM, Ladarola MJ. In vivo control of NMDA receptor transcript in motoneurons by viral transduction of a short antisense gene. Brain Res Mol Brain Res, 2001, 90:17~25.
  • 9[9]Delander GE,Schott E,Brodin E,et al. Spinal expression of mRNA for immediate early genes in a model of chronic pain. Acta Physiol Scand, 1997, 161:517~25.
  • 10[10]Zimmermann M, Herdegen T. Plasticy of the nervous system at the systematic, cellular and molecular levels: a mechanism of chronic pain and hyperalgesia. Prog Brain Res, 1996, 110:233~59.

共引文献10

同被引文献24

  • 1Secher NH,Van Lieshout JJ.Hypovolaemic shock and pain[J].Exp Physiol,2009,94(6):641-647.
  • 2Bremander A,Bergman S,Arvidsson B.Perception of multimodal cognitive treatment for people with chronic widespread pain-changing one's life plan[J].Disabil Rehabil,2009,21:1-9.
  • 3Koulousakis A,Kuchta J,Bayarassou A,et al.Intrathecal opioids for intractable pain syndromes[J].Acta Neurochir Suppl,2007,97(Pt 1):43-48.
  • 4De la O-Arciniega M,Díaz-Reval MI,Cortés-Arroyo AR,et al.Anti-nociceptive synergism of morphine and gabapentin in neuropathic pain induced by chronic constriction injury[J].Pharmacol Biochem Behav,2009,92(3):457-464.
  • 5Ho KY,Jones L,Gan TJ.The effect of cultural background on the usage of complementary and alternative medicine for chronic pain management[J].Pain Physician,2009,12(3):685-688.
  • 6Nichols DE,Frescas SP,Chemel BR,et al.High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO):a high-affinity 5-HT2A receptor-selective agonist radioligand[J].Bioorg Med Chem,2008,16(11):6116-6123.
  • 7Jain KK.Gene therapy for pain.Expert[J].Opin Biol Ther,2008,8(12):1855-1866.
  • 8Glorioso JC,Fink DJ.Herpes vector-mediated gene transfer in the treatment of chronic pain[J].Mol Ther,2009,17(1):13-18.
  • 9Foulkes T,Wood JN.Pain genes[J].PLOS Genet,2008,4(7):e1000086.
  • 10Mata M,Hao S,Fink DJ.Gene therapy directed at the neuroimmune component of chronic pain with particular attention to the role of TNF alpha[J].Neurosci Lett,2008,437(3):209-213.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部